Global Intravenous Solutions Market 2014-2018

Global Intravenous Solutions Market 2014-2018

Category : Pharmaceuticals
Published On : November  2013
Pages : 65

------------ Or -------------

TechNavio forecasts the Global Intravenous Solutions market to grow with a CAGR of 7.88 percent for the period 2013–2018. Several driving factors and trends will contribute to this growth—all of which will be outlined in detail in this report.  TechNavio’s analysts use a unique methodology to scrutinize individual vendor performance, trends, drivers, and challenges, and a number of other factors to provide the most accurate and detailed market research reports possible. 

A more specific breakdown of this report’s content has been listed below.

Overview of market share and landscape for the following key geographies:

• Americas

Overview and impact analysis of:

• 3 Market Drivers
• 3 Market Challenges
• 3 Market Trends

Market Shares and SWOT Analysis for these vendors: 
• Baxter International Inc. 
• B. Braun Melsungen AG 
• Fresenius Kabi AG 
• Hospira Inc.

Five Force Model Impact Analysis of:

• Suppliers
• Buyers
• Substitutes
• New Entrants 
• Market Competition 

Note: All of the segments above are supplemented with a combination of statistical data, graphical analysis, and verbal explanation. 

After purchasing any of our reports, you can request a one hour meeting to discuss any questions you may have with our team of analysts.


01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Geographical Segmentation

07.1 Intravenous Solutions Market in the Americas

07.1.1 Market Size and Forecast

07.2 Intravenous Solutions Market in the EMEA Region

07.2.1 Market Size and Forecast

07.3 Intravenous Solutions Market in the APAC Region

07.3.1 Market Size and Forecast

08. Key Leading Countries

08.1 Key Leading Countries in the Americas

08.1.1 USA

08.2 Key Leading Countries in the EMEA Region

08.2.1 Germany

08.2.2 UK

08.3 Key Leading Countries in the APAC Region

08.3.1 Japan

08.3.2 China

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

16.1 Competitive Scenario

16.1.1 Key News

16.1.2 Mergers and Acquisitions

16.2 Market Share Analysis 2013

16.3 Other Prominent Vendors

17. Key Vendor Analysis

17.1 B. Braun Melsungen AG

17.1.1 Business Overview

17.1.2 Business Segmentation

17.1.3 Key Information

17.1.4 SWOT Analysis

17.2 Baxter International Inc.

17.2.1 Business Overview

17.2.2 Business Segmentation

17.2.3 Key Information

17.2.4 SWOT Analysis

17.3 Fresenius Kabi AG

17.3.1 Business Overview

17.3.2 Business Segmentation

17.3.3 Key Information

17.3.4 SWOT Analysis

17.4 Hospira Inc.

17.4.1 Business Overview

17.4.2 Business Segmentation

17.4.3 Key Information

17.4.4 SWOT Analysis

18. Other Reports in this Series

List of Exhibits

Exhibit 1: Market Research Methodology

Exhibit 2: Global Intravenous Solutions Market 2013-2018 (US$ billion)

Exhibit 3: Global Intravenous Solutions Market by Geographical Segmentation 2013

Exhibit 4: Intravenous Solutions Market in the Americas 2013-2018 (US$ billion)

Exhibit 5: Intravenous Solutions Market in the EMEA Region 2013-2018 (US$ billion)

Exhibit 6: Intravenous Solutions Market in the APAC Region 2013-2018 (US$ billion)

Exhibit 7: Global Intravenous Solutions Market by Vendor Segmentation 2013

Exhibit 8: Business Segmentation of B. Braun Melsungen AG

Exhibit 9: Business Segmentation of Baxter International Inc.

Exhibit 10: Business Segmentation of Fresenius Kabi AG

Exhibit 11: Business Segmentation of Hospira Inc.


Enquiry Before Buy